Further comparative analyses revealed significantly higher plasma MIF levels in patients with obesity and without OSAS compared with normal weight patients with OSAS (p ≤ 0.001) and healthy donors (p = 0.0043), but also significantly increased MIF values in normal weight patients with OSAS compared with healthy control subjects (Fig. 6B). Here, MIF is linked to obesity disorder.